Drug-labels.com

Duratocin (Ferring, PM 00055704): Uses, Side Effects and Dosage

Updated:
Facts
Status:
Prescription (Rx) Current status: Cancelled Post Market
Strength:
100 mcg
Active ingredient:
ATC code:
Similar drugs:

Patient Medication Information: uses, side effects, how to take - Duratocin (Ferring, PM 00055704)

ABOUT THIS MEDICATION

What the medication is used for:

DURATOCIN is used to prevent loss of muscle tone in the uterus (womb) and heavy bleeding in women who have delivered a baby by caesarean section.

What it does:

In some women, after a caesarean, the womb doesn’t contract (shrink) quickly enough. This makes it more likely that they’ll bleed more than normal. DURATOCIN makes the womb contract and so reduces the risk of bleeding.

When it should not be used:

DURATOCIN must not be given until after the baby has been delivered.

Before giving you DURATOCIN, your doctor needs to know about any medical conditions you may have. You should also tell your doctor about any new symptoms that develop while you are being treated with DURATOCIN.

DURATOCIN must not be used:

  • If you are pregnant.

  • If you are allergic to carbetocin or any of the ingredients of DURATOCIN.
  • If you have any serious heart problems.
  • If you ever have had an allergic reaction to oxytocin (sometimes

    given as a drip or injection during or after labour).

  • In children younger than 18 years of age.

  • In elderly patients over 65 years of age.

What the medicinal ingredient is:

Carbetocin

What the nonmedicinal ingredients are:

Glacial acetic acid, sodium chloride, water for injection

What dosage forms it comes in:

Solution for injection, 100 mcg/mL

WARNINGS AND PRECAUTIONS

BEFORE you use DURATOCIN talk to your doctor or pharmacist if you have/are:

  • Liver or kidney problems
  • Pre-eclampsia (high blood pressure in pregnancy) or eclampsia (toxaemia of pregnancy).
  • If you have problems with your heart or your circulation (such as high blood pressure).
  • Epilepsy.
  • If you get migraines.
  • If you have asthma.
  • If you are breastfeeding. DURATOCIN may pass into your breast milk.

INTERACTIONS WITH THIS MEDICATION

Tell your doctor or pharmacist about your other medication, including the ones that you bought without prescription and natural health products.

The following may interact with DURATOCIN:

  • Medicines that cause blood vessels to narrow
  • Medicines that you breathe to put you to sleep for surgery, like halothane and cyclopropane
  • Prostaglandins, which are medicines to induce labour

PROPER USE OF THIS MEDICATION

Usual adult dose:

DURATOCIN is given as an intravenous injection immediately after your baby has been delivered by caesarean section under an epidural or spinal anaesthetic.

Overdose:

If you are accidentally given too much DURATOCIN, your womb may contract strongly and you could experience abdominal pain. You may also suffer drowsiness, listlessness and headache, caused by water building up in your body.

SIDE EFFECTS AND WHAT TO DO ABOUT THEM

Like all medicines, DURATOCIN can have side effects, but not everybody gets them. If you experience any other side effects not listed in this leaflet talk to your doctor.

Side effects may include:

  • Nausea, vomiting.
  • Stomach pain.
  • Itching, flushing.
  • Feeling of warmth.
  • Headache.
  • Shakiness.
  • Dizziness.
  • Metallic taste in the mouth.
  • Sweating, chills.

Duratocin (carbetocin injection) Page 28 of 28

  • Back pain.
SERIOUS SIDE EFFECTS, HOW OFTEN THEY HAPPEN AND WHAT TO DO ABOUT THEM
Symptom / effectTalk with your doctor or pharmacist

Stop taking drug and

seek immediate medical help

Only if severeIn all cases

Very

Common

Low blood pressure:

dizziness, fainting, light-headedness

May occur when you go from lying or sitting to standing up.

√
Common

Anemia:

fatigue, loss of energy, weakness.

Chest pain

Rapid heart beat

Breathlessness;

trouble breathing

Anxiety

√

√

√

√

√

This is not a complete list of side effects. For any unexpected effects while taking DURATOCIN, contact your doctor or pharmacist.

HOW TO STORE IT

Store at refrigerated temperature 2 – 8°C. Do not freeze.

Once ampoule has been opened, product must be used immediately.

Keep out of reach and sight of children.

REPORTING SUSPECTED SIDE EFFECTS

You can help improve the safe use of health products for Canadians by reporting serious and unexpected side effects to Health Canada. Your report may help to identify new side effects and change the product safety information.

3 ways to report:

  • Online at MedEffect (www.healthcanada.gc.ca/medeffect);
  • By calling 1-866-234-2345 (toll-free);
  • By completing a Consumer Side Effect Reporting Form and sending it by:

    • Fax to 1-866-678-6789 (toll-free), or
    • Mail to: Canada Vigilance Program

      Health Canada, Postal Locator 0701E Ottawa, ON

      K1A 0K9

      Postage paid labels and the Consumer Side Effect Reporting Form are available at MedEffect.

NOTE: Contact your health professional if you need information about how to manage your side effects. The Canada Vigilance Program does not provide medical advice.

MORE INFORMATION

If you want more information about DURATOCIN:

  • Talk to your healthcare professional
  • Find the full product monograph that is prepared for healthcare professionals and includes this Patient Medication Information by visiting the Health Canada website (www.healthcanada.gc.ca); or by calling Ferring Pharmaceuticals at 1-866-384-1314.

Last revised April 28, 2020

About this document

Source: Health Canada – Drug Product Database (DPD) and product monographs · DIN (Drug Identification Number): 02231593

Revision date stated in the text: April 28, 2020

Found a mistake? Write to us via the contact page.

The information on this site does not replace the advice of a doctor or pharmacist.

Drug information for Duratocin (Ferring, PM 00055704)

Rx or OTC
Prescription (Rx)?
DIN 02231593
Schedule(s) PRESCRIPTION
Active ingredient(s) Carbetocin 100 MCG
Dosage form(s) Solution
Route(s) of administration Intravenous
Drug class (WHO ATC)
  1. H Systemic hormonal preparations, excl. sex hormones and insulins
    1. H01 Pituitary and hypothalamic hormones and analogues
      1. H01B Posterior pituitary lobe hormones
        1. H01BB Oxytocin and analogues
          1. H01BB03 Carbetocin
Company FERRING INC
Current status Cancelled Post Market
Current status date May 18, 2021

Source: Health Canada – Drug Product Database (DPD) and product monographs, data as of November 1, 2026. Data from the Health Canada Drug Product Database, as published there. Not a substitute for the advice of a doctor or pharmacist.